库欣病诊断是否已超越双侧岩下窦采样?
单中心回顾性研究纳入1992至2021年229例ACTH依赖性库欣综合征患者,发现BIPSS使用率从68%降至26%,而MRI典型腺瘤检出率从40%升至69%,确诊CD比例稳定在83%至93%,提示影像学进步可安全减少BIPSS指征。
要点
- BIPSS使用率随时间下降,但库欣病确诊比例保持稳定。
- 垂体MRI典型腺瘤检出率上升,可能替代部分BIPSS。
- 现代影像学进步允许安全减少BIPSS的适应症。
核心结论
- BIPSS使用率随时间下降而未损失库欣病诊断效力,提示影像学进步可安全减少BIPSS指征。
研究设计与样本
- 单中心回顾性研究纳入229例连续ACTH依赖性库欣综合征患者,无明确内分泌肿瘤,1992至2021年接受激素检测(n=229)、垂体MRI(n=226)或CT(n=3)、胸腹部CT(n=114)及BIPSS(n=113)。
主要发现
- 三个十年(1992-2001、2002-2011、2012-2021)BIPSS使用率从68%降至49%和26%。
- 垂体MRI典型腺瘤检出率从40%升至58%和69%。
- 确诊CD比例分别为83%、81%、93%,保持稳定。
关键数值与推荐
- 意向诊断分析中,确诊CD 196例(86%)、疑似CD 24例(10%)、确诊EAS 5例(2%)、疑似EAS 4例(2%)。
临床怎么用
- 在影像学检出典型垂体腺瘤的患者中,可考虑减少BIPSS的使用。
局限性
- 单中心回顾性设计,部分患者最终诊断不确定(疑似CD 10%,疑似EAS 2%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Bilateral inferior petrosal sinus sampling (BIPSS) is the gold standard for distinguishing Cushing's Disease (CD) from Ectopic ACTH syndrome (EAS). It is however rarely evaluated in an intention-to diagnose-analysis, even though final diagnosis remains inconclusive in 7 to 39% of patients in published series. It has been suggested that BIPSS use may be reduced in patients explored by modern imaging and hormonal testing. We tested this hypothesis. DESIGN AND METHODS: Evolution of BIPSS use and diagnostic outcomes over time in a single-center retrospective study of 229 consecutive patients with ACTH-dependent-Cushing's syndrome (ACTH-CS) without evident endocrine tumors, explored from 1992 to 2021 with hormonal testing (n = 229); pituitary MRI (n = 226) or CT (n = 3); chest/abdominal CT scan (n = 114) and BIPSS (n = 113).In an intention-to-diagnose analysis, we classified outcomes as confirmed CD (cCD) or EAS (cEAS) if there was post-therapeutic evidence of an ACTH-secreting tumor, and suspected CD (sCD) or EAS (sEAS) if not, resulting in 196 cCD (86%), 24 sCD (10%), 5 cEAS (2%), 4 sEAS (2%). RESULTS: Comparing the 3 decades 1992-2001; 2002-2011; 2012-2021, the use of BIPSS decreased from 68% to 49% and 26%, while the frequency of a typical adenoma image at MRI increased from 40% to 58% and 69%. The proportion of patients with cCD (83%; 81%; 93%) remained stable. CONCLUSION: Our study demonstrates a decrease over time in the use of BIPSS without loss of efficacy in diagnosis of CD, suggesting that advances in imaging allow for a safe reduction in the indications for BIPSS.
引用
- Bouchard L, Lazard A, Jean C, et al. Is diagnosis of Cushing's disease moving beyond Bilateral inferior petrosal sinus sampling? J Clin Endocrinol Metab. 2026. PMID: 42411593. doi:10.1210/clinem/dgag265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。